Furthermore, high ARMC4 expression in CRC cells reduces NF-κB activity, cellular proliferation, anchorage-independent growth, and migratory ability in vitro and significantly decreases xenograft tumor growth in vivo, while shARMC4 knockdown has the opposite effect. This evidence concerns the gene NFKB1 and neoplasm.